KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rambus (RMBS) Cash & Equivalents (2016 - 2026)

Rambus has reported Cash & Equivalents over the past 18 years, most recently at $134.3 million for Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents rose 1.62% year-over-year to $134.3 million, compared with a TTM value of $134.3 million through Mar 2026, up 1.62%, and an annual FY2025 reading of $182.8 million, up 83.24% over the prior year.
  • Cash & Equivalents came in at $134.3 million for Q1 2026, down from $182.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $182.8 million in Q4 2025 to a low of $79.2 million in Q3 2025.
  • Median Cash & Equivalents over the past 5 years was $124.6 million (2024), compared with a mean of $125.5 million.
  • The sharpest move saw Cash & Equivalents tumbled 44.24% in 2023, then skyrocketed 83.24% in 2025.
  • Over 5 years, Cash & Equivalents stood at $125.3 million in 2022, then fell by 24.39% to $94.8 million in 2023, then increased by 5.28% to $99.8 million in 2024, then skyrocketed by 83.24% to $182.8 million in 2025, then decreased by 26.53% to $134.3 million in 2026.
  • Per Business Quant, the three most recent readings for RMBS's Cash & Equivalents are $134.3 million (Q1 2026), $182.8 million (Q4 2025), and $79.2 million (Q3 2025).